Zoetis Inc. (ZTS)
| Market Cap | 96.66B |
| Revenue (ttm) | 7.01B |
| Net Income (ttm) | 1.77B |
| Shares Out | 475.50M |
| EPS (ttm) | 3.71 |
| PE Ratio | 54.88 |
| Forward PE | 44.64 |
| Dividend | $0.85 |
| Dividend Yield | 0.42% |
| Trading Day | July 23 |
| Last Price | $203.59 |
| Previous Close | $200.54 |
| Change ($) | 3.05 |
| Change (%) | 1.52% |
| Day's Open | 201.74 |
| Day's Range | 200.62 - 203.94 |
| Day's Volume | 957,770 |
| 52-Week Range | 141.02 - 203.94 |
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
How Millennials And Gen Z Are Bringing Animal Health Stocks To New Highs
A year of pandemic lockdowns yielded a year of lavish attention for pets. Animal health stocks like Zoetis and Idexx Laboratories reflected that rise in affection.
The stock price of Zoetis, an animal health company, has seen a 10% rise over the last twenty-one trading days, while it is up 40% over the last year. ZTS stock has benefited from an increased animal ad...
AMRX vs. ZTS: Which Stock Is the Better Value Option?
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis is donating more than 11,000 doses of its experimental COVID-19 vaccine for animals to nearly 70 zoos across the U.S.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will host a webcast and conference call on second quarter 2021 financial results at 8:30 a.m. (ET) on Thursday, Aug. 5, 2021.
Stocks like PetIQ (PETQ), IDEXX Laboratories (IDXX), Phibro Animal Health (PAHC) and Zoetis (ZTS) offering animal health products and services make great picks for long term.
Zoetis stock has risen 2x from levels of $92 that it was at on March 23, 2020, when broader markets made a bottom, to levels of $184 now, while Merck's stock has underperformed and gained only 26% of it...
ZAVENTEM, Belgium--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis A.L.P.H.A. initiative improves livestock health and farmers' livelihoods in Sub-Saharan Africa
PARSIPPANY, N.J--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis today published its 2020 Sustainability Report describing its progress toward the company's long-term sustainability aspirations.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #WilliamBlair--Zoetis Inc. will participate in the William Blair 41st Annual Growth Stock Conference on Wednesday, June 2, 2021.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #fortune500--Zoetis Inc. (NYSE:ZTS) will participate in the Stifel 2021 Virtual Jaws & Paws Conference on Thursday, June 3, 2021.
BANGKOK--(BUSINESS WIRE)-- #BPTW4Thailand--Zoetis Thailand, an affiliate of the global animal health company dedicated to supporting customers and their businesses in ever better ways, has recently been...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #annualmeeting--Zoetis announced the results of shareholder voting at its 2021 Annual Meeting of Shareholders and provided details on its third quarter 2021 di...
Final Trades: Salesforce, EOG Resources, Las Vegas Sands & more
The "Halftime Report" traders give their top picks to watch for the second half.
While the market has taken a beating over recent days, pullbacks are the mother's milk of effective investment strategies, and shrewd market participants will already have a growing shopping list on han...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. announced leadership changes that will accelerate its long-term growth strategy in key markets and add new talent to its executive t...
AMRX vs. ZTS: Which Stock Is the Better Value Option?
When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?
Zoetis CEO discusses growth opportunities
Kristin Peck, Zoetis CEO, joins 'Closing Bell' to discuss growth opportunities at the company.
Bullish spending on pet health helped Zoetis easily beat first-quarter expectations. But Zoetis stock crumbled after the open.
Zoetis (ZTS) beat estimates for both earnings and revenues in the first quarter of 2021.
Zoetis (ZTS) delivered earnings and revenue surprises of 21.15% and 7.87%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis reports first quarter 2021 results.
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) will report earnings and revenues, and provide pipeline updates when it releases first-quarter 2021 results.
Zoetis (ZTS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
JAZZ vs. ZTS: Which Stock Is the Better Value Option?
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #earnings--Zoetis will report Q1 2021 financial results on May 6th.
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?
USNA vs. ZTS: Which Stock Is the Better Value Option?
Zoetis has proven to investors that the pharmaceutical apple doesn't fall far from the tree.
This leader in animal healthcare has shown strong financial performance through the years.
The animal health leader continues to invest in its future.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DrivenToCare--Zoetis today announced its long-term sustainability goals.
Zoetis Inc (NYSE: ZTS) seems well-positioned in 2021 with the stock valuation offering an attractive entry point, according to BofA Securities. The Zoetis Analyst: Michael Ryskin upgraded the rating for...
USNA vs. ZTS: Which Stock Is the Better Value Option?
Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Returning buyers and chief executives were among the insiders making purchases this week.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #fortune500--Zoetis will participate in the Cowen 41st Annual Health Care Conference on Monday, March 1, 2021.
When it comes to stocks to buy, we are getting more selective, and that's a good thing. In fact, buying pressure in more selective stocks means they may have more profit potential going forward.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. will participate in the Bank of America Securities 2021 Animal Health Summit Virtual Forum on Thursday, Feb. 25, 2021.
Animal health company Zoetis Inc (NYSE: ZTS) received the European Commission's marketing approval for Solensia (frunevetmab), an injectable monoclonal antibody for the alleviation of pain associated wi...
ZAVENTEM, Belgium--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis receives European Commission marketing authorization for Solensia® (frunevetmab), a new therapy for feline osteoarthritis pain.
Pet adoption theme will continue, says petcare company Zoetis' CEO
Pet care company Zoetis beat on the top and bottom lines after reporting earnings this morning. The company is seeing strong momentum for 2021, despite pandemic uncertainty.
Zoetis Inc. (NYSE: ZTS) said on Tuesday that its revenue in the fiscal fourth quarter saw an 8% annualised growth to £1.29 billion. Its net income in Q4 stood at £258.21 million that translates to 53.94...
Zoetis (ZTS) beats both earnings and sales estimates in the fourth quarter of 2020.
About ZTS
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Feb 1, 2013 |
| CEO Kristin Peck | Employees 11,300 |
| Stock Exchange NYSE | Ticker Symbol ZTS |
Financial Performance
In 2020, Zoetis's revenue was $6.68 billion, an increase of 6.63% compared to the previous year's $6.26 billion. Earnings were $1.64 billion, an increase of 9.20%.
Analyst Forecasts
According to 21 analysts, the average rating for Zoetis stock is "Buy." The 12-month stock price forecast is 192.81, which is a decrease of -5.29% from the latest price.